CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 141 filers reported holding CYTOKINETICS INC in Q4 2019. The put-call ratio across all filers is 1.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,667,436 | -28.3% | 56,600 | -20.6% | 0.00% | -42.9% |
| Q2 2023 | $2,324,697 | +45.3% | 71,266 | +104.1% | 0.01% | +40.0% |
| Q4 2022 | $1,599,759 | +128.2% | 34,914 | +141.4% | 0.01% | +66.7% |
| Q3 2022 | $701,000 | +59.3% | 14,464 | +29.1% | 0.00% | +200.0% |
| Q2 2022 | $440,000 | +69.2% | 11,200 | +96.5% | 0.00% | 0.0% |
| Q4 2021 | $260,000 | +29.4% | 5,700 | +1.8% | 0.00% | 0.0% |
| Q3 2021 | $201,000 | -22.4% | 5,600 | -53.3% | 0.00% | 0.0% |
| Q3 2020 | $259,000 | +32.8% | 11,979 | -29.9% | 0.00% | -50.0% |
| Q3 2019 | $195,000 | -21.4% | 17,100 | -22.3% | 0.00% | 0.0% |
| Q2 2019 | $248,000 | +202.4% | 22,000 | +117.8% | 0.00% | +100.0% |
| Q1 2019 | $82,000 | +720.0% | 10,100 | +1162.5% | 0.00% | – |
| Q4 2016 | $10,000 | -69.7% | 800 | -75.0% | 0.00% | – |
| Q4 2015 | $33,000 | +6.5% | 3,200 | -30.4% | 0.00% | – |
| Q3 2015 | $31,000 | – | 4,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,721,888 | $41,198,000 | 4.18% |
| Virtus ETF Advisers LLC | 93,309 | $672,000 | 0.58% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 105,324 | $758,000 | 0.55% |
| LANSDOWNE PARTNERS (UK) LLP | 2,647,981 | $19,065,000 | 0.20% |
| WASATCH ADVISORS LP | 1,761,882 | $12,686,000 | 0.16% |
| PINNACLE ASSOCIATES LTD | 888,415 | $6,397,000 | 0.12% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 84,690 | $610,000 | 0.08% |
| Birchview Capital, LP | 10,000 | $72,000 | 0.05% |
| Piermont Capital Management Inc. | 16,530 | $119,000 | 0.04% |
| Tekla Capital Management LLC | 137,797 | $992,000 | 0.04% |